Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX), sold 15,624 shares at $61.24 ($957K) on 2024-04-18, disclosed to the SEC on 2024-04-22.
Scheduled sale ($957k) by PRESIDENT AND CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.24 | 7,624 | $467K | 48.8% |
| 2 | $61.24 | 7,624 | $467K | 48.8% |
| 3 | $61.90 | 376 | $23K | 2.4% |
| Total | $61.26 avg | 15,624 | $957K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |